Practice effects and the use of alternate forms in serial neuropsychological testing

被引:255
作者
Beglinger, LJ
Gaydos, B
Tangphao-Daniels, O
Duff, K
Kareken, DA
Crawford, J
Fastenau, PS
Siemers, ER
机构
[1] Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Indiana Univ, Sch Med, Dept Neurol, Bloomington, IN 47405 USA
[4] Indiana Univ Purdue Univ, Dept Psychol, Indianapolis, IN 46205 USA
关键词
cognition; neuropsychological; practice effects; learning; clinical trials; phase I;
D O I
10.1016/j.acn.2004.12.003
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Accurate understanding of practice characteristics, performance stability, and error on neuropsychological tests is essential to both valid clinical assessment and maximization of signal detection for clinical trials of cognitive enhancing drugs. We examined practice effects in 28 healthy adults. As part of a larger study using donepezil and simulating a Phase I trial, participants were randomized into: placebo, no-treatment and donepezil. Donepezil results are presented elsewhere. Neuropsychological tests were administered in a fixed order for 6 weeks, with alternate forms available for most tests. Despite alternate forms, ANOVAs revealed significant improvements for the pooled control group (placebo and no-treatment) on all tests except Letter Number Sequencing and Trails B. Learning occurred principally in the first three to four sessions. PASAT and Stroop interference showed the greatest learning. Thus, serial assessment with alternate forms may attenuate retest effects on some tests, but continued learning occurs on novel tests or those in which an advantageous test-taking strategy can be identified. Alternate forms and baseline practice sessions may help control early, rapid improvements in clinical trials. (c) 2005 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:517 / 529
页数:13
相关论文
共 37 条
[1]  
[Anonymous], 1992, CLIN NEUROPSYCHOL, DOI DOI 10.1080/13854049208404115
[2]  
[Anonymous], J INT NEUROPSYCHOL S
[3]  
[Anonymous], J INT NEUROPSYCHOL S
[4]  
[Anonymous], 2004, Neuropsychological Assessment
[5]   Practice effects on the WAIS-III across 3-and 6-month intervals [J].
Basso, MR ;
Carona, FD ;
Lowery, N ;
Axelrod, BN .
CLINICAL NEUROPSYCHOLOGIST, 2002, 16 (01) :57-63
[6]   Neuropsychological test performance in healthy volunteers before and after donepezil administration [J].
Beglinger, LJ ;
Gaydos, BL ;
Kareken, DA ;
Tangphao-Daniels, O ;
Siemers, ER ;
Moh, RC .
JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (01) :102-108
[7]   Neuropsychological practice effects and change detection in people with schizophrenia [J].
Beglinger, LJ ;
Crawford-Miller, J ;
Kareken, DA ;
Ahmed, S ;
Derby, MA ;
Siemers, E ;
Fastenau, PS ;
Shekhar, A .
SCHIZOPHRENIA RESEARCH, 2003, 62 (1-2) :191-194
[8]   Practice effects during repeated administrations of memory tests with and without alternate forms [J].
Benedict, RHB ;
Zgaljardic, DJ .
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1998, 20 (03) :339-352
[9]   Revision of the brief visuospatial memory test: Studies of normal performance, reliability, and validity [J].
Benedict, RHB ;
Schretlen, D ;
Groninger, L ;
Dobraski, M ;
Shpritz, B .
PSYCHOLOGICAL ASSESSMENT, 1996, 8 (02) :145-153
[10]  
CLAUS JJ, 1991, J PSYCHIATR NEUROSCI, V16, P1